SILVER POINT CAPITAL L.P. purchased 2.9% of their position (130.97K shares) of KEENOVA THERAPEUTICS PLC on the open market
Open‑market purchase worth $11.62M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/10/2025ACC: 0001193125-25-314511
10% Owner
Since Nov 2025
+130.97K
Net shares
Net buyer
$11.62M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
130.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+130.97K
Price / share
$88.75
Trade value
$11.62M
% of position
2.9%
12/8/2025
4.57M→4.70M
Total
Net shares
+130.97K
Net value
$11.62M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/8/2025 | P · Purchase | +130.97K | $88.75 | $11.62M | 2.9% | 4.57M | 4.70M |
| Total | +130.97K | $11.62M | ||||||
Derivative Transactions0
No derivative transactions reported